Leatherhead Food Research UK
Leatherhead, Randalls Road, Surrey, KT22 7RY, United Kingdom
NCT Number: NCT02671214
Identify one or more flat bread mixes that produce a reduction in positive incremental area under the curve (iAUC) of post-prandial glucose relative to the control product.
Looking for future studies?
Notify Me20 year–50 year
All sexes
Interventional
Not applicable
Leatherhead, Randalls Road, Surrey, KT22 7RY, United Kingdom
This study was a double-blind, randomised, balanced incomplete block design exploratory study of efficacy, with 11 active treatments compared to a control product in 42 healthy subjects to see if a mix of active ingredients (viscous fibres and flours) lowered the post-prandial glucose (PPG) response in capillary blood (finger prick) over a two and three hours period, relative to the control product. Every subject received the control and 4 out of the 11 treatments on five separate test days.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
100 g high fibre flour
98 g high fibre flour + 2 g guar gum
88 g high fibre flour + 2 g guar gum + 10 g legume flour
83 g high fibre flour + 2 g guar gum + 15 g legume flour
96 g high fibre flour + 4 g guar gum
86 g high fibre flour + 4 g guar gum + 10 g legume flour
81 g high fibre flour + 4 g guar gum + 15 g legume flour
94 g high fibre flour + 6 g guar gum
98 g high fibre flour + 2 g konjac mannan
96 g high fibre flour + 4 g konjac mannan
100 g low fibre flour
85 g high fibre flour + 15 g legume flour
Time frame: 120 minutes
Time frame: 180 minutes
Unilever R&D
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details